AKW6AnitaWagnerAnita Katharina Wagner, D.P.H., Dr.Pharm.42.34529500000000-71.1005760000000011538Wagner, AnitaKatharina617/509-9956Associate Professor of Population Medicinecatalyst:eCommonsLogineCommons Loginprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 1049911429489428Wharam JF, Zhang F, Lu CY, Wagner AK, Nekhlyudov L, Earle CC, Soumerai SB, Ross-Degnan DJournal of clinical oncology : official journal of the American Society of Clinical OncologyBreast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. J Clin Oncol. 2018 04 10; 36(11):1121-1127.J Clin Oncol2018-02-28T00:00:002018Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.7780383Wagner AK, Vickrey BGQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationThe routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda. Qual Life Res. 1995 Apr; 4(2):169-77.Qual Life Res1995-04-01T00:00:001995The routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda.Wagner AK, Shea CC, Sant GInterstitial Cystitis. Sant G, ed.Health-related quality of life issues. Interstitial Cystitis. Sant G, ed. 1997; 261-270.1997-01-01T00:00:001997Health-related quality of life issues9248315Wagner AK, Ehrenberg BL, Tran TA, Bungay KM, Cynn DJ, Rogers WHQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationPatient-based health status measurement in clinical practice: a study of its impact on epilepsy patients' care. Qual Life Res. 1997 May; 6(4):329-41.Qual Life Res1997-05-01T00:00:001997Patient-based health status measurement in clinical practice: a study of its impact on epilepsy patients' care.9817109Wagner AK, Gandek B, Aaronson NK, Acquadro C, Alonso J, Apolone G, Bullinger M, Bjorner J, Fukuhara S, Kaasa S, Leplège A, Sullivan M, Wood-Dauphinee S, Ware JEJournal of clinical epidemiologyCross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 Nov; 51(11):925-32.J Clin Epidemiol1998-11-01T00:00:001998Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment.Wagner AKEpilepsy in our experience. Stories of health care professionals as care providers and patientsA description by a care provider, contributed to: Schachter SC, Rowan AJ. The brainstorms healer. Epilepsy in our experience. Stories of health care professionals as care providers and patients. 1998.1998-01-01T00:00:001998A description by a care provider, contributed to: Schachter SC, Rowan AJ. The brainstorms healer8305795Bungay KM, Wagner AKThe Annals of pharmacotherapyComment: assessing the quality of pharmaceutical care. Ann Pharmacother. 1993 Dec; 27(12):1542-3.Ann Pharmacother1993-12-01T00:00:001993Comment: assessing the quality of pharmaceutical care.Authorship 1065972329754304Lu CY, Zhang F, Wagner AK, Nekhlyudov L, Earle CC, Callahan M, LeCates R, Xu X, Ross-Degnan D, Wharam JFBreast cancer research and treatmentImpact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer. Breast Cancer Res Treat. 2018 Aug; 171(1):235-242.Breast Cancer Res Treat2018-05-12T00:00:002018Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.Authorship 1068723429788313Leopold C, Peppercorn JM, Zafar SY, Wagner AKJournal of the National Cancer InstituteDefining Value of Cancer Therapeutics-A Health System Perspective. J Natl Cancer Inst. 2018 07 01; 110(7):699-703.J Natl Cancer Inst2018-07-01T00:00:002018Defining Value of Cancer Therapeutics-A Health System Perspective.21640554Zhang F, Wagner AK, Ross-Degnan DJournal of clinical epidemiologySimulation-based power calculation for designing interrupted time series analyses of health policy interventions. J Clin Epidemiol. 2011 Nov; 64(11):1252-61.J Clin Epidemiol2011-11-01T00:00:002011Simulation-based power calculation for designing interrupted time series analyses of health policy interventions.Authorship 1070023229855813Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L, Ross-Degnan D, Wharam JFBreast cancer research and treatmentTotal and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans. Breast Cancer Res Treat. 2018 Sep; 171(2):449-459.Breast Cancer Res Treat2018-06-01T00:00:002018Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.15277291Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan DArchives of internal medicineBenzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004 Jul 26; 164(14):1567-72.Arch Intern Med2004-07-26T00:00:002004Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PCHealth Policy. Epub ahead of print. doi:10.1016/j.healthpol.2008.07.001 Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. Epub ahead of print. doi:10.1016/j.healthpol.2008.07.001. 2008.2008-01-01T00:00:002008Medicine access and utilization in a population covered by primary health care in BrazilWagner AK, Soumerai SB, Graves AJ, Briesacher B, Zhang F, Gurwitz J, Ross-Degnan DCatastrophic expenses and lack of access to health care and medications among middle-aged Americans (submitted). 2008.2008-03-01T00:00:002008Catastrophic expenses and lack of access to health care and medications among middle-aged Americans (submitted)Authorship 1073902629909874Lu CY, Zhang F, Golonski N, Lupton C, Jeffrey P, Wagner AKValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes ResearchState Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015. Value Health. 2018 06; 21(6):692-697.Value Health2017-11-07T00:00:002017State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015.23192243Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AKBMJ openImpact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012; 2(6).BMJ Open2012-11-28T00:00:002012Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study.Wagner AK, Massaro FJAn assessment of U.S. pharmaceutical donations: Players, processes, and products. Reich MR, ed.Classification of donated drugs. An assessment of U.S. pharmaceutical donations: Players, processes, and products. Reich MR, ed. 1999.1999-01-01T00:00:001999Classification of donated drugsWagner AKInternational Epilepsy NewsAssessing the health-related quality of life of people with epilepsy. International Epilepsy News. 1993; 27(114):12-14 (letter).1993-01-01T00:00:001993Assessing the health-related quality of life of people with epilepsyAuthorship 1076349729944628Garabedian LF, Sinaiko AD, Ross-Degnan D, Abu-Jaber T, Hoefer M, Oddleifson S, Wagner AKQuality management in health careQuality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices. Qual Manag Health Care. 2018 Jul/Sep; 27(3):157-164.Qual Manag Health Care2018-07-01T00:00:002018Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices.Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PCBMC Health Serv Res. Published online 2008 October 31. doi: 10.1186/1472-6963-8-222.A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Serv Res. Published online 2008 October 31. doi: 10.1186/1472-6963-8-222. 2008.2008-10-31T00:00:002008A descriptive review of the methodologies used in household surveys on medicine utilization17227933Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, Soumerai SBAnnals of internal medicineEffect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007 Jan 16; 146(2):96-103.Ann Intern Med2007-01-16T00:00:002007Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates.Rogers W, Wittink H, Wagner A, Cynn D, Carr DPain MedAssessing individual outcomes during outpatients' multidisciplinary chronic pain therapy by means of an augmentes SF-36. Pain Med. 2000; 1(1):44-54.2000-03-01T00:00:002000Assessing individual outcomes during outpatients' multidisciplinary chronic pain therapy by means of an augmentes SF-36Wagner AKRobert Wood Johnson Foundation Investigator Awards in Health Policy ProgramThe social determinants of health working group report. Robert Wood Johnson Foundation Investigator Awards in Health Policy Program. 1998.1998-01-01T00:00:001998The social determinants of health working group reportProceedings of the Second International Conference on Improving the Use of Medicines. Available at http://mednet3.who.int/icium/icium2004/proceedings.asp. 2004.2004-04-02T00:00:002004Proceedings of the Second International Conference on Improving the Use of Medicines. Available at http://mednet3.who.int/icium/icium2004/proceedings.aspAuthorship 10881721130120741Gagne JJ, Popovic JR, Nguyen M, Sandhu SK, Greene P, Izem R, Jiang W, Wang Z, Zhao Y, Petrone AB, Wagner AK, Dutcher SKDrug safetyEvaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs. Drug Saf. 2018 12; 41(12):1313-1323.Drug Saf2018-12-01T00:00:002018Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs.7780379Wagner AK, Keller SD, Kosinski M, Baker GA, Jacoby A, Hsu MA, Chadwick DW, Ware JEQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationAdvances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. Qual Life Res. 1995 Apr; 4(2):115-34.Qual Life Res1995-04-01T00:00:001995Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life.8700786Wagner AK, Bungay KM, Kosinski M, Bromfield EB, Ehrenberg BLPharmacotherapyThe health status of adults with epilepsy compared with that of people without chronic conditions. Pharmacotherapy. 1996 Jan-Feb; 16(1):1-9.Pharmacotherapy1996-01-01T00:00:001996The health status of adults with epilepsy compared with that of people without chronic conditions.20170478Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, Ntaganira J, Balikuddembe R, Chalker J, Wagner AKBMC health services researchMeasuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010 Feb 19; 10:42.BMC Health Serv Res2010-02-19T00:00:002010Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.Wagner AK, Gandek B, Ware JESF-36 Health Survey: A Handbook for IQOLA Project Investigators. 2007.2007-01-01T00:00:002007SF-36 Health Survey: A Handbook for IQOLA Project InvestigatorsZhang F, Wagner AK, Soumerai S, Ross-Degnan D.Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series data. 2002; 748-754.2002-09-29T00:00:002002Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series dataWagner AK, Ross-Degnan D, Gurwitz J, Soumerai SBAnn Intern MedBenzodiazepines and hip fractures. Letter to the Editor. Ann Intern Med. 2007; 147(5):348.2007-09-04T00:00:002007Benzodiazepines and hip fractures. Letter to the Editor7552916Wagner AK, Bungay KM, Bromfield EB, Ehrenberg BLAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsAssessing the health status of adult patients with epilepsy. Am J Health Syst Pharm. 1995 Jul 15; 52(14 Suppl 3):S29-31.Am J Health Syst Pharm1995-07-15T00:00:001995Assessing the health status of adult patients with epilepsy.20473197Briesacher BA, Ross-Degnan D, Wagner AK, Fouayzi H, Zhang F, Gurwitz JH, Soumerai SBMedical careOut-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy. Med Care. 2010 Jun; 48(6):503-9.Med Care2010-06-01T00:00:002010Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.Authorship 1083861WHO Geneva, Department of Technical Cooperation on Essential Drugs and Traditional Medicines. Using Indicators to Measure Country Pharmaceutical Situations – Fact Book on WHO Level I and Level II Monitoring Indicators. World Health Organization: Geneva. 2006.2006-01-01T00:00:002006WHO Geneva, Department of Technical Cooperation on Essential Drugs and Traditional Medicines. Using Indicators to Measure Country Pharmaceutical Situations – Fact Book on WHO Level I and Level II Monitoring Indicators. World Health Organization: Geneva12174032Wagner AK, Soumerai SB, Zhang F, Ross-Degnan DJournal of clinical pharmacy and therapeuticsSegmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002 Aug; 27(4):299-309.J Clin Pharm Ther2002-08-01T00:00:002002Segmented regression analysis of interrupted time series studies in medication use research.15916061Suttajit S, Wagner AK, Tantipidoke R, Ross-Degnan D, Sitthi-amorn CThe Southeast Asian journal of tropical medicine and public healthPatterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok. Southeast Asian J Trop Med Public Health. 2005 Mar; 36(2):489-97.Southeast Asian J Trop Med Public Health2005-03-01T00:00:002005Patterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok.Briesacher BA, Ross-Degnan D, Adams AS, Wagner AK, Gurwitz J, Soumerai SBJ Health and Soc Policy Review (in press).Redefining the affordability of medication expenditures among Medicaid enrollees. J Health and Soc Policy Review (in press). 2008.2008-01-01T00:00:002008Redefining the affordability of medication expenditures among Medicaid enrolleesD055553Chemicals & Drugs2925940.581296Prescription DrugsD018954Chemicals & Drugs39730.907583Drugs, EssentialD014486Organizations76915840.547727United States Food and Drug AdministrationD016527Concepts & Ideas43011150.552759Drug CostsD017277Activities & Behaviors3757420.602462Drug ApprovalHealth Care PolicyHealth Policy and ManagementMedicinePopulation MedicinePharmacologyBrigham and Women's HospitalHarvard Medical SchoolHarvard Pilgrim HealthcareHarvard T.H. Chan School of Public HealthCYL3ChristineLuChristine Lu, Ph.D.45019Lu, ChristineVisiting Professor of Population MedicineKL118KimberlyLaneKimberly Lane, M.P.H.42.34529500000000-71.100576000000002109Lane, KimberlyResearch Associate in Population MedicineSBS5StephenSoumeraiStephen Bertram Soumerai, Sc.D.42.34529500000000-71.1005760000000031734Soumerai, StephenProfessor of Population MedicineNLK2NancyKeatingNancy Lynn Keating, M.D.42.33610940000000-71.1008845000000017235Keating, NancyProfessor of Health Care PolicyDGR2DennisRoss-DegnanDennis Ross-Degnan, Sc.D.42.34529500000000-71.1005760000000049840Ross-Degnan, DennisAssociate Professor of Population MedicineMK31MichaelKlompasMichael Klompas, M.D.42.34529500000000-71.1005760000000015769Klompas, MichaelProfessor of Population MedicineRP6RichardPlattRichard Platt, M.D.42.34529500000000-71.1005760000000066284Platt, RichardHarvard Pilgrim Health Care Institute Professor of Population MedicineBDS3BenjaminSommersBenjamin Daniel Sommers, M.D., Ph.D.42.33510370000000-71.1061649000000068121Sommers, BenjaminHuntley Quelch Professor of Health Care EconomicsJSB28JeffreyBrownJeffrey Stuart Brown, Ph.D.42.34529500000000-71.1005760000000037397Brown, JeffreyLecturer on Population Medicine, Part-timeASP4AntoinettePetersAntoinette S. Peters, Ph.D.42.34529500000000-71.1005760000000030769Peters, AntoinetteCorresponding Member of the Faculty of Population MedicineJLA2JeromeAvornJerome Lewis Avorn, M.D.42.33370900000000-71.1037950000000056961Avorn, JeromeProfessor of Medicine1190selected publications1.690410.00266153247research areas5.449830.011720825coauthor of50.957610.832660similar toAuthorship 1175006531325147Leopold C, Araujo-Lane C, Rosenberg C, Gilkey M, Wagner AKPharmacoEconomics - openOut-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program. Pharmacoecon Open. 2020 Jun; 4(2):389-392.Pharmacoecon Open2020-06-01T00:00:002020Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program.true1Professor of MedicineProfessor of MedicineAuthorship 1417893Authorship 1834431Authorship 1243626332334579Leopold C, Lu CY, Wagner AKBMC health services researchIntegrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand. BMC Health Serv Res. 2020 Apr 25; 20(1):351.BMC Health Serv Res2020-04-25T00:00:002020Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand.Authorship 1853001Authorship 1953961Authorship 1293042433021165Leopold C, Haffajee RL, Lu CY, Wagner AKThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & EthicsThe Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts. J Law Med Ethics. 2020 09; 48(3):538-551.J Law Med Ethics2020-09-01T00:00:002020The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts.Authorship 13057386Authorship 1306067433170746Ferrario A, Xu X, Zhang F, Ross-Degnan D, Wharam JF, Wagner AKJCO oncology practiceIntensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States. JCO Oncol Pract. 2021 02; 17(2):e194-e203.JCO Oncol Pract2020-11-10T00:00:002020Intensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States.33177183Darrow JJ, Sharma M, Shroff M, Wagner AKScience translational medicineEfficacy and costs of spinal muscular atrophy drugs. Sci Transl Med. 2020 11 11; 12(569).Sci Transl Med2020-11-11T00:00:002020Efficacy and costs of spinal muscular atrophy drugs.Authorship 2269439Authorship 1346789333844270Hughes TM, Empringham B, Wagner AK, Ward ZJ, Yeh J, Gupta S, Frazier AL, Denburg AECancerForecasting essential childhood cancer drug need: An innovative model-based approach. Cancer. 2021 08 15; 127(16):2990-3001.Cancer2021-04-12T00:00:002021Forecasting essential childhood cancer drug need: An innovative model-based approach.Authorship 14048403Authorship 14051641034661616Shahzad M, Naci H, Wagner AKJAMA internal medicineEstimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval. JAMA Intern Med. 2021 12 01; 181(12):1673-1675.JAMA Intern Med2021-12-01T00:00:002021Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval.34661604Fu M, Naci H, Booth CM, Gyawali B, Cosgrove A, Toh S, Xu Z, Guan X, Ross-Degnan D, Wagner AKJAMA internal medicineReal-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018. JAMA Intern Med. 2021 12 01; 181(12):1596-1604.JAMA Intern Med2021-12-01T00:00:002021Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018.Authorship 1422523634986008Ferrario A, Zhang F, Ross-Degnan D, Wharam JF, Twaddle ML, Wagner AKJCO oncology practiceUse of Palliative Care Among Commercially Insured Patients With Metastatic Cancer Between 2001 and 2016. JCO Oncol Pract. 2022 05; 18(5):e677-e687.JCO Oncol Pract2022-01-05T00:00:002022Use of Palliative Care Among Commercially Insured Patients With Metastatic Cancer Between 2001 and 2016.Authorship 1461050235839466Haug NR, Wagner AK, McGlynn KA, Leonard CE, Nguyen MD, Major JMCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyNew-Onset Cancer Cases in FDA's Sentinel System: A Large Distributed System of US Electronic Healthcare Data. Cancer Epidemiol Biomarkers Prev. 2022 10 04; 31(10):1890-1895.Cancer Epidemiol Biomarkers Prev2022-10-04T00:00:002022New-Onset Cancer Cases in FDA's Sentinel System: A Large Distributed System of US Electronic Healthcare Data.Authorship 1502177136218446Wagner AK, Ubel PA, Wharam JFJAMA health forumFinancial Pollution in the US Health Care System. JAMA Health Forum. 2021 Mar 01; 2(3):e210195.JAMA Health Forum2021-03-01T00:00:002021Financial Pollution in the US Health Care System.Authorship 1518909336705931Shahzad M, Naci H, Wagner AKJAMAAssociation Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway. JAMA. 2023 03 07; 329(9):760-761.JAMA2023-03-07T00:00:002023Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway.Authorship 15830321137517625Xu S, Kitchen C, Liu Y, Kabba JA, Hayat K, Wang X, Wang G, Zhang F, Chang J, Fang Y, Wagner AK, Ross-Degnan DInternational journal of antimicrobial agentsEffect of a national antibiotic stewardship intervention in China targeting carbapenem overuse: An interrupted time-series analysis. Int J Antimicrob Agents. 2023 Oct; 62(4):106936.Int J Antimicrob Agents2023-07-28T00:00:002023Effect of a national antibiotic stewardship intervention in China targeting carbapenem overuse: An interrupted time-series analysis.Authorship 3759531true1Professor of Health Care PolicyProfessor of Health Care Policytrue1Assistant Professor of MedicineAssistant Professor of Medicinetrue1Instructor in MedicineInstructor in Medicinetrue1Professor of Population MedicineProfessor of Population Medicinetrue1Associate Professor of Population MedicineAssociate Professor of Population Medicinetrue1Associate Professor of Population MedicineAssociate Professor of Population Medicinetrue1Corresponding Member of the Faculty of Population MedicineCorresponding Member of the Faculty of Population Medicinetrue1Assistant Professor of Population MedicineAssistant Professor of Population Medicinetrue1Lecturer on Population Medicine, Part-timeLecturer on Population Medicine, Part-timetrue1Professor of Population MedicineProfessor of Population Medicinetrue1Huntley Quelch Professor of Health Care EconomicsHuntley Quelch Professor of Health Care Economicstrue1Research Associate in Population MedicineResearch Associate in Population Medicinetrue1Visiting Professor of Population MedicineVisiting Professor of Population Medicinetrue1Harvard Pilgrim Health Care Institute Professor of Population MedicineHarvard Pilgrim Health Care Institute Professor of Population Medicinetrue1Research Fellow in Population MedicineResearch Fellow in Population MedicineAuthorship 610895Authorship 1696422Authorship 2785072Authorship 2750601Authorship 33886123822552Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wagner AKInternational journal for equity in healthHealth care payments in the Asia Pacific: validation of five survey measures of economic burden. Int J Equity Health. 2013 Jul 03; 12:49.Int J Equity Health2013-07-03T00:00:002013Health care payments in the Asia Pacific: validation of five survey measures of economic burden.AS629AmeetSarpatwariAmeet Sarpatwari, J.D., Ph.D.120732Sarpatwari, AmeetAssistant Professor of MedicineAuthorship 621753Authorship 6857064Authorship 6854532Authorship 6891861Authorship 6882071Authorship 6879875Authorship 6885795Authorship 2251654Authorship 358711Authorship 731005324314624Hsu JC, Lu CY, Wagner AK, Chan KA, Lai MS, Ross-Degnan DHealth policy (Amsterdam, Netherlands)Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study. Health Policy. 2014 Jun; 116(2-3):196-205.Health Policy2013-11-20T00:00:002013Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study.Authorship 3716091Authorship 747941225104348Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan DThe Lancet. Global healthAccess to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Lancet Glob Health. 2013 Oct; 1(4):e227-37.Lancet Glob Health2013-09-24T00:00:002013Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.Authorship 755278125164588Wagner AK, Quick JD, Ross-Degnan DBMC health services researchQuality use of medicines within universal health coverage: challenges and opportunities. BMC Health Serv Res. 2014 Aug 27; 14:357.BMC Health Serv Res2014-08-27T00:00:002014Quality use of medicines within universal health coverage: challenges and opportunities.Authorship 604810Authorship 605743Authorship 608750Authorship 629352LBF8LauraGarabedianLaura Faden Garabedian, Ph.D.3930Garabedian, LauraAssistant Professor of Population MedicineAuthorship 57746125798948Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AKPloS onePolicies and programs to facilitate access to targeted cancer therapies in Thailand. PLoS One. 2015; 10(3):e0119945.PLoS One2015-03-23T00:00:002015Policies and programs to facilitate access to targeted cancer therapies in Thailand.Authorship 2098702Authorship 595690Authorship 586143Authorship 2282902Authorship 2749434Authorship 614357Authorship 2168021Authorship 33221Authorship 579336Authorship 7972535Authorship 8026205Authorship 805172625815201Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AKJournal of pharmaceutical policy and practiceUptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. J Pharm Policy Pract. 2015; 8(1):7.J Pharm Policy Pract2015-02-16T00:00:002015Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.25815200Lu CY, Lupton C, Rakowsky S, Babar ZU, Ross-Degnan D, Wagner AKJournal of pharmaceutical policy and practicePatient access schemes in Asia-pacific markets: current experience and future potential. J Pharm Policy Pract. 2015; 8(1):6.J Pharm Policy Pract2015-02-16T00:00:002015Patient access schemes in Asia-pacific markets: current experience and future potential.Authorship 604821Authorship 595992Authorship 817831325976425Hsu JC, Ross-Degnan D, Wagner AK, Zhang F, Lu CYClinical therapeuticsHow Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid? Clin Ther. 2015 Jul 01; 37(7):1420-1432.e1.Clin Ther2015-05-11T00:00:002015How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?Authorship 3522722Authorship 3860433Authorship 4232412Authorship 593697Authorship 835040325255920Vialle-Valentin CE, Serumaga B, Wagner AK, Ross-Degnan DHealth policy and planningEvidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries. Health Policy Plan. 2015 Oct; 30(8):1044-52.Health Policy Plan2014-09-24T00:00:002014Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.Authorship 858120326797230Leopold C, Chambers JD, Wagner AKValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes ResearchThirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change? Value Health. 2016 Jan; 19(1):14-6.Value Health2015-12-02T00:00:002015Thirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change?Authorship 601417Authorship 872006226988346Sruamsiri R, Wagner AK, Ross-Degnan D, Lu CY, Dhippayom T, Ngorsuraches S, Chaiyakunapruk NBMJ openExpanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis. BMJ Open. 2016 Mar 17; 6(3):e008671.BMJ Open2016-03-17T00:00:002016Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.Authorship 496014Authorship 612309BNR6BenjaminRomeBenjamin N Rome, M.D.108737Rome, BenjaminInstructor in MedicineAuthorship 5913042Assistant Professor1Associate Professor6Fellow or Post Doc0Full Professor4Instructor3Lecturer5Other FacultyAuthorship 623395Authorship 890540227342456Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JFBreast cancer research and treatmentRacial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):333-40.Breast Cancer Res Treat2016-06-24T00:00:002016Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.Authorship 620764Authorship 629362Authorship 984973Authorship 4966741Authorship 586060Authorship 622993Authorship 609127Authorship 927364227696008Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JFBreast cancer research and treatmentErratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 11; 160(2):385.Breast Cancer Res Treat2016-11-01T00:00:002016Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.Authorship 589499Authorship 368019110457743Wagner AK, Wyss K, Gandek B, Kilima PM, Lorenz S, Whiting DQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationA Kiswahili version of the SF-36 Health Survey for use in Tanzania: translation and tests of scaling assumptions. Qual Life Res. 1999; 8(1-2):101-10.Qual Life Res1999-01-01T00:00:001999A Kiswahili version of the SF-36 Health Survey for use in Tanzania: translation and tests of scaling assumptions.10691113Dworetzky BA, Hoch DB, Wagner AK, Salmanson E, Shanahan CW, Bromfield EBEpilepsiaThe impact of a single seizure on health status and health care utilization. Epilepsia. 2000 Feb; 41(2):170-6.Epilepsia2000-02-01T00:00:002000The impact of a single seizure on health status and health care utilization.10457744Wyss K, Wagner AK, Whiting D, Mtasiwa DM, Tanner M, Gandek B, Kilima PMQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationValidation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Qual Life Res. 1999; 8(1-2):111-20.Qual Life Res1999-01-01T00:00:001999Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania.18664285Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan DBMC health services researchCosts of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res. 2008 Jul 29; 8:161.BMC Health Serv Res2008-07-29T00:00:002008Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines.14527986Wagner AK, Soumerai SB, Zhang F, Mah C, Simoni-Wastila L, Cosler L, Fanning T, Gallagher P, Ross-Degnan DInternational journal for quality in health care : journal of the International Society for Quality in Health CareEffects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care. 2003 Oct; 15(5):423-31.Int J Qual Health Care2003-10-01T00:00:002003Effects of state surveillance on new post-hospitalization benzodiazepine use.15673345Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JHJournal of the American Geriatrics SocietyPotentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc. 2005 Feb; 53(2):227-32.J Am Geriatr Soc2005-02-01T00:00:002005Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001.16294363Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt RPharmacoepidemiology and drug safetyFDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):369-86.Pharmacoepidemiol Drug Saf2006-06-01T00:00:002006FDA drug prescribing warnings: is the black box half empty or half full?10973406Wittink H, Hoskins Michel T, Wagner A, Sukiennik A, Rogers WSpineDeconditioning in patients with chronic low back pain: fact or fiction? Spine (Phila Pa 1976). 2000 Sep 01; 25(17):2221-8.Spine (Phila Pa 1976)2000-09-01T00:00:002000Deconditioning in patients with chronic low back pain: fact or fiction?21842245Nekhlyudov L, Li L, Ross-Degnan D, Wagner AKBreast cancer research and treatmentFive-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat. 2011 Nov; 130(2):681-9.Breast Cancer Res Treat2011-08-13T00:00:002011Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.Wagner AK, Reiss S, Graves AJ, Ross-Degnan DResults of feasibility study using World Health Survey data to measure medicines need, use, and out-of-pocket expenditures in eight low and lower-middle income countriesResults of feasibility study using World Health Survey data to measure medicines need, use, and out-of-pocket expenditures in eight low and lower-middle income countries. 2007.2007-03-23T00:00:002007Results of feasibility study using World Health Survey data to measure medicines need, use, and out-of-pocket expenditures in eight low and lower-middle income countries20828854Wagner AK, Graves AJ, Reiss SK, Lecates R, Zhang F, Ross-Degnan DHealth policy (Amsterdam, Netherlands)Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy. 2011 May; 100(2-3):151-8.Health Policy2010-09-09T00:00:002010Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey.Authorship 986054328449884Leopold C, Morgan SG, Wagner AKHealth policy (Amsterdam, Netherlands)A rapidly changing global medicines environment: How adaptable are funding decision-making systems? Health Policy. 2017 Jun; 121(6):637-643.Health Policy2017-04-10T00:00:002017A rapidly changing global medicines environment: How adaptable are funding decision-making systems?Authorship 989534328606975Morgan SG, Leopold C, Wagner AKCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneDrivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage. CMAJ. 2017 Jun 12; 189(23):E794-E799.CMAJ2017-06-12T00:00:002017Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.10870147Wittink H, Michel TH, Kulich R, Wagner A, Sukiennik A, Maciewicz R, Rogers WSpineAerobic fitness testing in patients with chronic low back pain: which test is best? Spine (Phila Pa 1976). 2000 Jul 01; 25(13):1704-10.Spine (Phila Pa 1976)2000-07-01T00:00:002000Aerobic fitness testing in patients with chronic low back pain: which test is best?18973675Vialle-Valentin CE, Ross-Degnan D, Ntaganira J, Wagner AKHealth research policy and systemsMedicines coverage and community-based health insurance in low-income countries. Health Res Policy Syst. 2008 Oct 30; 6:11.Health Res Policy Syst2008-10-30T00:00:002008Medicines coverage and community-based health insurance in low-income countries.Suttajit S, Tantipidoke R, Wagner AK, Ross-Degnan D, Sitthi-amorn CDecisions about medication use by adults with respiratory infections in Bangkok slum communities: Implications for interventions to reduce antimicrobial resistance. Submitted. 2006.2006-01-01T00:00:002006Decisions about medication use by adults with respiratory infections in Bangkok slum communities: Implications for interventions to reduce antimicrobial resistance. SubmittedAF230AlessandraFerrarioAlessandra Ferrario, Ph.D.162824Ferrario, AlessandraResearch Fellow in Population Medicine23505420Wagner AK, Graves AJ, Fan Z, Walker S, Zhang F, Ross-Degnan DPloS oneNeed for and access to health care and medicines: are there gender inequities? PLoS One. 2013; 8(3):e57228.PLoS One2013-03-07T00:00:002013Need for and access to health care and medicines: are there gender inequities?10516789Reich MR, Wagner AK, McLaughlin TJ, Dumbaugh KA, Derai-Cochin MBulletin of the World Health OrganizationPharmaceutical donations by the USA: an assessment of relevance and time-to-expiry. Bull World Health Organ. 1999; 77(8):675-80.Bull World Health Organ1999-01-01T00:00:001999Pharmaceutical donations by the USA: an assessment of relevance and time-to-expiry.Strassels SA, McNichol E, Wagner AK, Rogers WH, Gouveia WA, Carr DBAcute PainPersistent postoperative pain, health-realted quality of life, and functioning 1 month after hospital discharge. Acute Pain. 2004; 6(3-4):95-104.2004-12-01T00:00:002004Persistent postoperative pain, health-realted quality of life, and functioning 1 month after hospital discharge7552913Bungay KM, Wagner AKAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsIntroduction to pharmacist participation in measuring and monitoring patients' health-related quality of life. Am J Health Syst Pharm. 1995 Jul 15; 52(14 Suppl 3):S19-23.Am J Health Syst Pharm1995-07-15T00:00:001995Introduction to pharmacist participation in measuring and monitoring patients' health-related quality of life.Wagner AK, Ross-Degnan D Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific. K. Eggleston, Editor, under review.The potential for insurance systems to increase access to and appropriate use of medicines in Asia-Pacific countries. Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific. K. Eggleston, Editor, under review. 2008.2008-01-01T00:00:002008The potential for insurance systems to increase access to and appropriate use of medicines in Asia-Pacific countries401 Park DrHarvard Pilgrim Health Care InstituteLandmark Center401 Park DrBoston02215MA19010644Zhang F, Wagner AK, Soumerai SB, Ross-Degnan DJournal of clinical epidemiologyMethods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol. 2009 Feb; 62(2):143-8.J Clin Epidemiol2008-11-17T00:00:002008Methods for estimating confidence intervals in interrupted time series analyses of health interventions.Vialle-Valentin C, Ross-Degnan D, Wagner AKHealth Res Policy Syst. Published online 2008 October 30. doi: 10.1186/1478-4505-6-11Medicine Coverage and Community-Based Health Insurance in Low-Income Countries. Health Res Policy Syst. Published online 2008 October 30. doi: 10.1186/1478-4505-6-11. 2008.2008-10-30T00:00:002008Medicine Coverage and Community-Based Health Insurance in Low-Income CountriesWagner AKQuality of Life NewsletterInternational Quality of Life Assessment (IQOLA)Project. Quality of Life Newsletter. 1992; 3:5.1992-01-01T00:00:001992International Quality of Life Assessment (IQOLA)ProjectWagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan DBMC Health Serv Res. Published online 2008 July 29. doi: 10.1186/1472-6963-8-161.Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res. Published online 2008 July 29. doi: 10.1186/1472-6963-8-161. 2008.2008-07-29T00:00:002008Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the PhilippinesWagner AKPharmacoeconomics and outcomes: Applications for patient care. Bungay KM, Osterhaus JT, Paladino JA, Sanchez LA, eds.Using patient-based assessments for individual patient care. Pharmacoeconomics and outcomes: Applications for patient care. Bungay KM, Osterhaus JT, Paladino JA, Sanchez LA, eds. 1997; 363-416.1997-01-01T00:00:001997Using patient-based assessments for individual patient careZhang F, Wagner AK, Soumerai SB, Ross-Degnan DJournal of Clinical Epidemiology. Epub ahead of print doi:10.1016/j.jclinepi.2008.08.007 Methods for estimating confidence intervals in interrupted time series analyses of health interventions. Journal of Clinical Epidemiology. Epub ahead of print doi:10.1016/j.jclinepi.2008.08.007. 2008.2008-08-09T00:00:002008Methods for estimating confidence intervals in interrupted time series analyses of health interventions